C Cabrera
2 Papers
27 Citations
C Cabrera is an academic researcher. The author has contributed to research in topics: Rituximab & CD20. The author has an hindex of 1, co-authored 2 publications.
Chat about Author
Papers
Rituximab in CD20 positive multiple myeloma
TL;DR: In the letter of Moreau, the result of a small trial of the treatment with rituximab as a single agent in patients with multiple myeloma that expresses CD20 is reported, there is no benefit for the patients newly diagnosed or relapsed with CD20þ MM.
32
Reply to Gozzetti et al.
TL;DR: It is stressed that this type of association has never been explored in any trial or single patient experience and the use of rituximab as a single agent was ineffective in CD20+MM.